Well to start with an obvious flaw in Cancer drugs is that their effectiveness seems to diminish as the cancer cells mutate and render the drug ineffective after a few months, also the kind of cells that are involved can be of other varieties ( other than suspected).....all this does not accord with Cancer reasearch and funding as one size fits all drugs could never be produced presently, and therefore the glimpse of temporary remissions satisfy current expectations.
Market Data 
Markets 
AI
